A. Hussein et al., Pulmonary veno-occlusive disease, antiphospholipid antibody and pulmonary hypertension in an adolescent, KLIN PADIAT, 211(2), 1999, pp. 92-95
Pulmonary veno-occlusive disease (PVOD) is a rare cause of pulmonary hypert
ension (PH); Antiphospholipid antibody (APL) is another known cause of pulm
onary hypertension, due to recurrent pulmonary thromboembolism. The coincid
ence of both causes, PVOD and APL, without thromboembolism, in PH has not b
een reported previously in children.
A 12.5-year-old boy presented with a one year history of fatigue. Pulmonary
hypertension was diagnosed by echocardiography. Pulmonary function tests r
evealed a moderate restrictive pattern and elevated granulocytes were detec
ted in bronchoalveolar lavage. An isolated high-titer APL was detected. Ope
n lung biopsy established the diagnosis of PVOD, with no evidence of pulmon
ary thrombosis, but with accompanying interstitial and alveolar cellular in
filtration. We speculate that APL may have played a role in the pathogenesi
s of PVOD. Prednison improved the symptoms of the interstitial pneumonitis
and was stopped, on follow up of 30 months, the patient ist in stable condi
tion on therapy with nifedipin, phenprocoumon and digoxin.
Conclusions PVOD and APL may be present simultaneously as a rare cause of P
H. Interstitial pneumonitis map accompany PVOD and produce the leading symp
toms. Open lung biopsy is essential for early establishment of the diagnosi
s.